Xiao-xiao Wang
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 14, 2023
The beneficial effect of Escalated-R-CHOP-21 for the treatment of diffuse large B-cell lymphoma in elderly male patients: A propensity-matched cohort study.
Journal: Cancer medicine
Published: January 05, 2021
Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study.
Journal: Annals of hematology
Published: December 02, 2020
Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
Journal: Bone marrow transplantation
Published: August 24, 2020
Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
Journal: Leukemia & lymphoma
Published: January 17, 2019
Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 22, 2015
Safety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20+ non-Hodgkin's lymphoma.
Journal: Expert opinion on drug safety
Published: November 22, 2014
Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: a phase II study.
Journal: Leukemia & lymphoma
Published: February 18, 2014
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Journal: Expert opinion on pharmacotherapy
Published: December 04, 2013
Last Updated: 09/26/2026